Format

Send to

Choose Destination
See comment in PubMed Commons below
JAMA. 2010 Mar 10;303(10):979-80. doi: 10.1001/jama.2010.257.

Building comparative efficacy and tolerability into the FDA approval process.

Author information

1
University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. alec_oconnor@urmc.rochester.edu
PMID:
20215612
DOI:
10.1001/jama.2010.257
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center